Terms: = Endocrine gland cancer AND CBL, RNF55, 867, ENSG00000110395, C-CBL, CBL2 AND Prognosis
15 results:
1. Positive
Huang S; Qi M; Tian T; Dai H; Tang Y; Huang R
Front Endocrinol (Lausanne); 2022; 13():959089. PubMed ID: 36407316
[TBL] [Abstract] [Full Text] [Related]
2. Evaluation of plasma exosomal miRNAs as potential diagnostic biomarkers of lymph node metastasis in papillary thyroid carcinoma.
Chen W; Li G; Li Z; Zhu J; Wei T; Lei J
Endocrine; 2022 Mar; 75(3):846-855. PubMed ID: 34854020
[TBL] [Abstract] [Full Text] [Related]
3. Establishment and verification of the nomogram that predicts the 3-year recurrence risk of epithelial ovarian carcinoma.
Hu J; Jiao X; Zhu L; Guo H; Wu Y
BMC Cancer; 2020 Sep; 20(1):938. PubMed ID: 32993522
[TBL] [Abstract] [Full Text] [Related]
4. Radiomic analysis for preoperative prediction of cervical lymph node metastasis in patients with papillary thyroid carcinoma.
Lu W; Zhong L; Dong D; Fang M; Dai Q; Leng S; Zhang L; Sun W; Tian J; Zheng J; Jin Y
Eur J Radiol; 2019 Sep; 118():231-238. PubMed ID: 31439247
[TBL] [Abstract] [Full Text] [Related]
5. The time point of completion thyroidectomy has no prognostic impact in patients with differentiated thyroid cancer.
Lenschow C; Mäder U; Germer CT; Reiners C; Schlegel N; Verburg FA
Clin Endocrinol (Oxf); 2019 Mar; 90(3):479-486. PubMed ID: 30548672
[TBL] [Abstract] [Full Text] [Related]
6. A cancer of undetermined significance: Incidental thyroid carcinoma.
Evranos B; Polat SB; Cuhaci FN; Baser H; Topaloglu O; Kilicarslan A; Kilic M; Ersoy R; Cakir B
Diagn Cytopathol; 2019 May; 47(5):412-416. PubMed ID: 30488670
[TBL] [Abstract] [Full Text] [Related]
7. The ambiguous role of microRNA-205 and its clinical potential in pancreatic ductal adenocarcinoma.
Michael Traeger M; Rehkaemper J; Ullerich H; Steinestel K; Wardelmann E; Senninger N; Abdallah Dhayat S
J Cancer Res Clin Oncol; 2018 Dec; 144(12):2419-2431. PubMed ID: 30244390
[TBL] [Abstract] [Full Text] [Related]
8. MicroRNA-29b-2-5p inhibits cell proliferation by directly targeting cbl-b in pancreatic ductal adenocarcinoma.
Li C; Dong Q; Che X; Xu L; Li Z; Fan Y; Hou K; Wang S; Qu J; Xu L; Wen T; Yang X; Qu X; Liu Y
BMC Cancer; 2018 Jun; 18(1):681. PubMed ID: 29940895
[TBL] [Abstract] [Full Text] [Related]
9. Microscopic Venous Invasion in Pancreatic cancer.
Yamada M; Sugiura T; Okamura Y; Ito T; Yamamoto Y; Ashida R; Sasaki K; Nagino M; Uesaka K
Ann Surg Oncol; 2018 Apr; 25(4):1043-1051. PubMed ID: 29302820
[TBL] [Abstract] [Full Text] [Related]
10. MicroRNA-891b is an independent prognostic factor of pancreatic cancer by targeting cbl-b to suppress the growth of pancreatic cancer cells.
Dong Q; Li C; Che X; Qu J; Fan Y; Li X; Li Y; Wang Q; Liu Y; Yang X; Qu X
Oncotarget; 2016 Dec; 7(50):82338-82353. PubMed ID: 27494897
[TBL] [Abstract] [Full Text] [Related]
11. Is screening for pancreatic cancer in high-risk groups cost-effective? - Experience from a Danish national screening program.
Joergensen MT; Gerdes AM; Sorensen J; Schaffalitzky de Muckadell O; Mortensen MB
Pancreatology; 2016; 16(4):584-92. PubMed ID: 27090585
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic significance of the highest peripancreatic lymph node in biliary tract adenocarcinoma.
Kelly KJ; Dukleska K; Kuk D; Kingham TP; D'Angelica MI; DeMatteo RP; Allen PJ; Jarnagin WR; Fong Y
Ann Surg Oncol; 2014 Mar; 21(3):979-85. PubMed ID: 24212720
[TBL] [Abstract] [Full Text] [Related]
13. Integrative survival-based molecular profiling of human pancreatic cancer.
Donahue TR; Tran LM; Hill R; Li Y; Kovochich A; Calvopina JH; Patel SG; Wu N; Hindoyan A; Farrell JJ; Li X; Dawson DW; Wu H
Clin Cancer Res; 2012 Mar; 18(5):1352-63. PubMed ID: 22261810
[TBL] [Abstract] [Full Text] [Related]
14. Altered down regulation of the receptor tyrosine kinase met in pancreatic adenocarcinoma cells.
Hill KS; Lorinczi M; Elferink LA
J Exp Ther Oncol; 2010; 8(4):297-312. PubMed ID: 21222362
[TBL] [Abstract] [Full Text] [Related]
15. Gene expression profiling identifies markers of ampullary adenocarcinoma.
Van Heek NT; Maitra A; Koopmann J; Fedarko N; Jain A; Rahman A; Iacobuzio-Donahue CA; Adsay V; Ashfaq R; Yeo CJ; Cameron JL; Offerhaus JA; Hruban RH; Berg KD; Goggins M
Cancer Biol Ther; 2004 Jul; 3(7):651-6. PubMed ID: 15136764
[TBL] [Abstract] [Full Text] [Related]
